Our Services
Medical Information
Helpful Resources
Published on: 2/28/2026
ALS is a progressive neurodegenerative disease where motor neurons die, so the brain can no longer signal muscles, leading to weakness, atrophy, and eventual failure of movement, speech, swallowing, and breathing.
There is no cure, but FDA approved therapies and early, multidisciplinary care can slow decline, so seek prompt medical evaluation, request neurologist testing like EMG, consider genetic counseling if relevant, and treat breathing or swallowing issues as urgent; there are several factors to consider, and key details that can change your next steps are outlined below.
If you've been asking what is ALS, you're likely looking for clear, honest information. ALS is a serious neurological condition, but understanding it can help you take practical, medically sound next steps.
Amyotrophic lateral sclerosis (ALS) is a progressive disease that affects the nerve cells (motor neurons) that control voluntary muscles. These are the muscles you use to move, speak, swallow, and breathe. Over time, ALS causes these nerve cells to break down and die. When that happens, the brain can no longer send signals to the muscles. As a result, muscles weaken, shrink (atrophy), and eventually stop working.
ALS is sometimes called Lou Gehrig's disease, named after the famous baseball player who was diagnosed with it.
To understand what ALS is, it helps to know how movement works:
In ALS:
Importantly, ALS typically does not affect:
People with ALS are often mentally aware of what's happening, which can make emotional support especially important.
Muscles fail in ALS because they lose their connection to motor neurons.
When motor neurons die:
The process is gradual but relentless. Early on, symptoms may be subtle. Over time, weakness spreads to more parts of the body.
ALS is considered a neurodegenerative disease. The exact cause is not fully understood, but researchers believe it may involve:
In most people (about 90–95%), ALS occurs without a known family history. This is called sporadic ALS.
Symptoms vary from person to person, depending on which motor neurons are affected first.
Common early symptoms include:
As ALS progresses, symptoms may include:
ALS does not usually cause numbness, tingling, or significant pain in the early stages. If sensory symptoms are dominant, another condition may be more likely.
If you're experiencing any combination of these symptoms and want to better understand whether they warrant urgent medical evaluation, you can use a free AI-powered tool to check symptoms specific to Amyotrophic Lateral Sclerosis (ALS) and receive guidance on appropriate next steps.
However, an online tool is not a diagnosis. A physician evaluation is essential.
There is no single test that confirms ALS. Diagnosis is based on:
Doctors must rule out other diseases that can mimic ALS, such as:
A neurologist—especially one specializing in neuromuscular diseases—is usually involved in confirming the diagnosis.
Currently, there is no cure for ALS. However, there are FDA-approved treatments that can:
Approved medications may modestly extend survival or slow functional decline. These treatments work best when started early.
Research is ongoing, and new therapies continue to be studied.
If you are wondering what is ALS because you are experiencing symptoms, take practical, evidence-based steps:
If you notice:
Make an appointment with your primary care physician or request a referral to a neurologist.
Anything that affects breathing, swallowing, or rapid muscle loss should be treated as potentially serious. Speak to a doctor immediately about anything that could be life-threatening or serious.
A neurologist can:
Early evaluation is important. Some ALS-like symptoms are caused by conditions that are treatable.
If you have:
Genetic counseling may help clarify your risk.
If diagnosed, care is often provided by a team that may include:
Multidisciplinary clinics are associated with improved quality of life and survival.
ALS progresses differently for each person. On average, survival is 3–5 years after symptom onset, but some people live much longer.
Management focuses on:
Assistive devices can significantly improve independence, including:
These interventions are not about giving up—they are about maintaining safety, dignity, and comfort.
Because ALS affects physical function but often leaves thinking intact, emotional health is critical.
Helpful supports include:
Early involvement of palliative care does not mean end-of-life care. It means symptom-focused support alongside active treatment.
Seek immediate medical attention if you experience:
These can be medical emergencies.
So, what is ALS? It is a progressive neurodegenerative disease that damages motor neurons, leading to muscle weakness and eventual muscle failure. It is serious and currently incurable, but early medical evaluation and multidisciplinary care can improve both survival and quality of life.
If you are worried about symptoms:
Most muscle weakness is not caused by ALS. Many other conditions are far more common and often treatable. But persistent, progressive weakness deserves medical attention.
If something feels serious or life-threatening—especially breathing or swallowing problems—speak to a doctor immediately.
Clear information, early evaluation, and appropriate medical care are your best next steps.
(References)
* Brown RH, Al-Chalabi A. Amyotrophic Lateral Sclerosis. N Engl J Med. 2017 Aug 10;377(12):162-172. doi: 10.1056/NEJMra1603471. PMID: 28792874.
* Hardiman O, Al-Chalabi A, Chio A, Diekstra F, Eisen A, et al. Amyotrophic Lateral Sclerosis: An Update on Etiology, Pathogenesis, Diagnosis, and Treatment. J Neurol. 2018 Jan;265(1):1-14. doi: 10.1007/s00415-017-8547-0. Epub 2017 Jun 24. PMID: 28647895.
* Mehta P, Kaye W, Bryan L, Solem M, Fagan L, Chiò A, Rowland LP, Sufit RL, Salameh JS, Bedlack RS, Rosenfeld J, Glass JD. Amyotrophic Lateral Sclerosis: A Review of Current and Future Therapies. JAMA Neurol. 2021 May 1;78(5):618-629. doi: 10.1001/jamaneurol.2021.0097. PMID: 33755030.
* Gagliardi D, Zoccolella S, Maimone S. Drug Development for Amyotrophic Lateral Sclerosis: A Critical Review. J Pers Med. 2022 Mar 22;12(3):511. doi: 10.3390/jpm12030511. PMID: 35339247; PMCID: PMC8954756.
* Tintignac C, Lagarrigue S. Molecular mechanisms underlying muscle atrophy in amyotrophic lateral sclerosis. Front Mol Neurosci. 2023 Jul 19;16:1193301. doi: 10.3389/fnmol.2023.1193301. PMID: 37537989; PMCID: PMC10395726.
We would love to help them too.
For First Time Users
We provide a database of explanations from real doctors on a range of medical topics. Get started by exploring our library of questions and topics you want to learn more about.
Was this page helpful?
Purpose and positioning of servicesUbie Doctor's Note is a service for informational purposes. The provision of information by physicians, medical professionals, etc. is not a medical treatment. If medical treatment is required, please consult your doctor or medical institution. We strive to provide reliable and accurate information, but we do not guarantee the completeness of the content. If you find any errors in the information, please contact us.